Table 2.
Men |
Women |
|||
Year(s) | 2019 | 2019 | ||
Mean age (range) | 43 (21–75) | 39 (20–72) | ||
Sample size |
n = 26 |
n = 28 |
||
Concentrations |
% <LOD |
Concentrations |
% <LOD |
|
trans-Nonachlor | 5.6 (<1.42–120) | 8 | 2.7 (<1.43–14) | 32 |
Hexachlorobenzene | 18 (7.0–76) | 0 | 12 (4.0–47) | 0 |
p,p’-DDE | 46 (19–290) | 0 | 38 (13–220) | 0 |
PCB138 | 3.8 (<1.42–38) | 15 | 2.7 (<1.43–17) | 29 |
PCB153 | 7.8 (2.6–66) | 3.8 | 5.2 (<1.4b–32) | 14 |
PCB180 | 5.2 (<1.42–30) | 12 | 3.7 (<1.43–24) | 29 |
PBDE47 | 5.4 (<4.32–56) | 38 | <4.23 (<4.23–25) | 61 |
PBDE153 | 6.1 (<4.32–35) | 31 | 4.2 (<4.23–32) | 50 |
PFOA | 1.1 (0.65–1.7) | 0 | 0.76 (0.41–1.7) | 0 |
PFNA | 1.2 (0.46–3.9) | 0 | 0.77 (0.37–2.0) | 0 |
PFDA | 0.20 (<0.09–0.57) | 13 | 0.16 (<0.09–0.35) | 13 |
PFHxS | 0.56 (0.28–1.2) | 0 | 0.26 (0.10–1.4) | 0 |
PFOS | 1.4 (0.60–3.9) | 7.7 | 0.78 (<0.40–2.4) | 14 |
1.LOD: Limit of detection; values <LOD were replaced by LOD/2 for the purposes of calculating means.
2.based on the geometric mean (7.0 g/L) of blood lipids observed for male participants.
3.based on the geometric mean (7.1 g/L) of blood lipids observed for female participants.